Showing 841 - 860 results of 100,422 for search '(( 10 ((nn decrease) OR (teer decrease)) ) OR ( 5 ((a decrease) OR (mean decrease)) ))', query time: 1.14s Refine Results
  1. 841
  2. 842
  3. 843
  4. 844
  5. 845

    Image 5_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…The treatment also reduced the key tight junction protein, occludin, at the cell membrane, and increased acidic mucins and extracellular alkaline phosphatase activity. Additionally, GDC decreased cAMP, suggesting its mechanism of action was via activation of a G-protein coupled receptor. …”
  6. 846
  7. 847
  8. 848
  9. 849

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”
  10. 850

    Acute JMV2959 treatment decreases alcohol preference in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”
  11. 851
  12. 852

    Acute JMV2959 treatment decreases alcohol intake in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) The acute effects of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) administration on alcohol intake was evaluated at 1 hour time interval after both two and five months of voluntary alcohol consumption. …”
  13. 853
  14. 854
  15. 855
  16. 856
  17. 857
  18. 858
  19. 859
  20. 860